Shin JW, He Q, Suk YJ, Kim SH, et al. Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk. Osteoporos Int 2022 Aug 4. pii: 10.1007/s00198-022-06495.
PMID: 35925259